Reported medication events in a paediatric emergency research network: sharing to improve patient safety

Kathy N Shaw1, Kathleen A Lillis, Richard M Ruddy

  • 1Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104-1902, USA. Shaw@email.chop.edu

Insights

Paediatric medication errors in emergency departments (EDs) were analyzed from incident reports. Most errors stemmed from human factors, with few resulting in severe harm, indicating areas for intervention.

Area of Science:

  • Pediatric Emergency Medicine
  • Patient Safety
  • Medication Error Analysis

Background:

  • Medication errors are a significant cause of preventable harm in pediatric emergency departments (EDs).
  • Voluntary incident reporting (IR) systems are common in hospitals but often lack external data sharing.
  • Analysis of 597 pediatric medication events (MEs) from 18 EDs between 2007-2008.

Purpose of the Study:

  • To describe the analysis of pediatric medication events (MEs) reported in emergency departments (EDs).
  • To identify common medication categories, error types, and contributing human factors.
  • To understand the outcomes of medication errors and adverse reactions in pediatric ED settings.

Main Methods:

  • Confidential, deidentified incident reports (IRs) were collected from 18 pediatric EDs.
  • Medication events (MEs) were independently categorized by two investigators, with discrepancies resolved by consensus.
  • Analysis focused on medication errors, including dose errors, look-alike/sound-alike issues, and contributing human factors.

Main Results:

  • Medication errors constituted 94% of the 597 reported MEs.
  • Incorrect medication doses were frequently linked to incorrect weight, duplicate dosing, and miscalculation.
  • Human factors, such as procedural failures and communication issues, contributed to 85% of reports; 13% of MEs resulted in patient harm.

Conclusions:

  • Incident reporting systems provide valuable data on pediatric medication errors in EDs.
  • Analysis identified key medication categories and human factors contributing to errors.
  • Findings suggest targeted interventions are needed to reduce pediatric medication errors and improve systems issues.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...